Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Primidone in Adults with Amyotrophic Lateral Sclerosis (Single-arm Phase 2 Trial)
ChiCTR2500110065Phase 2Not yet recruiting
- Sponsor
- The First College of Clinical Medical Science, China Three Gorges University
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of primidone in amyotrophic lateral sclerosis (ALS), sponsored by The First College of Clinical Medical Science, China Three Gorges University. Primary endpoint: Change in progression rate of ALSFRS-R score compared to baseline at week 78. Planned start Sep 2025; status: not yet recruiting.
02
Drugs
primidone
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on ChiCTR2500110065.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500110065.